CELLULAR CULTURE MEDIUM FREE FROM SERUM

20220041989 · 2022-02-10

Assignee

Inventors

Cpc classification

International classification

Abstract

The present invention relates to a cell culture medium, in particular for culturing autologous fibroblasts, for use in aesthetic medicine for skin transplantation, said culture medium being serum-free and being characterized in that it contains glucose in a much lower quantity than conventional culture media.

Claims

1-9. (canceled)

10. A method for improving biomechanical properties of skin comprising transplanting to a subject in need thereof a cell culture of fibroblasts expanded in a saline aqueous solution consisting of: a mixture of biologically acceptable mineral salts consisting of sodium chloride, potassium chloride, sodium bicarbonate, sodium dihydrogen phosphate, magnesium chloride and calcium chloride, D-glucose, Vitamin B6 and vitamin C, and water; wherein in the saline aqueous solution glucose is in a concentration<6 mM, vitamin C is in a concentration of between 0.05 mM and 2 mM and vitamin B6 is in a concentration of between 5 mM and 20 mM.

11. The method of claim 10, wherein in the saline aqueous solution the concentration of glucose is 5.5 mM.

12. The method according to claim 10, wherein said aqueous solution is a modified Tyrode's solution and consists of the following components in the respective millimolar concentrations: TABLE-US-00004 NaCl 130 mM, KCl 2.68 mM, D-Glucose 5.5 mM, NaHCO3 11.9 mM, NaH2PO4 0.46 mM, MgCl2 1.05 mM, CaCl2 1.8 mM, Vitamin C 0.1-1 mM, and Vitamin B6 10 mM.

Description

DESCRIPTION OF FIGURES

[0021] FIG. 1 shows in graphical presentation the MTT assay results on % cell viability of fibroblasts after 24 hours of incubation in DMEM, DMEM+PBS, PBS only, conventional Tyrode's solution, a solution according to the present invention in the presence of Vitamin C (0.1 mM) and Vitamin B6 (10 mM) and a solution according to the present invention in the presence of Vitamin C (1 mM), and Vitamin B6 (10 mM), respectively.

[0022] FIG. 2 shows proliferation of human fibroblasts (cell counting) after a 24 hours' incubation in the following culture media: DMEM only, DMEM+PBS, PBS only, conventional Tyrode's solution, a solution according to the present invention in the presence of Vitamin C (0.1 mM), Vitamin B6 (10 mM) and a solution according to the present invention in the presence of Vitamin C (1 mM), Vitamin B6 (10 mM).

DETAILED DESCRIPTION OF THE INVENTION

[0023] Preferably the saline solution of the invention has a concentration of the component b), i.e. D-glucose, of 5.5 mM.

[0024] Preferably the water-soluble vitamins of the present invention are selected from at least one of the following: Vitamin C, Vitamin B12, Vitamin B6, Vitamin B5 or Pantothenic Acid, Biotin, Nicotinamide or the amide form of Vitamin B3, the salt form of α-Lipoic Acid or Vitamin N.

[0025] Preferably the saline solution of the invention contains at least the combination of Vitamin C and Vitamin B6.

[0026] Preferably for the objects of the present invention by Vitamin B6 it is intended pyridoxine, pyridoxamine hydrochloride, pyridoxal o pyridoxal phosphate.

[0027] Preferably, the Vitamin C is present at a concentration between 0.05 mM and 2 mM and the Vitamin B6 is present at a concentration ranging between 5 mM and 20 mM.

[0028] According to a particularly preferred embodiment of the invention, the saline solution of the present invention consists of the following components in their respective millimolar concentrations:

TABLE-US-00002 NaCl 130 mM, KCl 2.68 mM, D-Glucose 5.5 mM, NaHCO.sub.3 11.9 mM, NaH.sub.2PO.sub.4 0.46 mM, MgCl.sub.2 1.05 mM, CaCl.sub.2 1.8 mM, Vitamin C 0.1-1 mM, Vitamin B6 10 mM.

[0029] Experimental evidences of cell viability and cellular proliferation of fibroblasts carried on cell cultures in DMEM, DMEM+PBS, only PBS, conventional Tyrode's solution, a solution according to the present invention in the presence of Vitamin C (0.1 mM), Vitamin B6 (10 mM) and a solution according to the present invention in the presence of Vitamin C (1 mM), and Vitamin B6 (10 mM), respectively, are reported for illustrative purposes herein below.

Example

[0030] Method

[0031] The cells (primary human dermal fibroblasts) were grown in standard amplification conditions (37° C., 5% CO.sub.2, 95% humidity in the incubator) in the following culture liquids [0032] DMEM [0033] DMEM supplemented with antibiotics and 10% serum, in the culture liquid containing PBS serum (10%) [0034] Standard Tyrode [0035] Two Tyrode's solutions modified according to the invention and containing each Vitamin B6 at a concentration of 10 mM and Vitamin C at a concentration of 0.1 and 1 mM, respectively.

[0036] Conventional or standard Tyrode's formulations and modified Tyrode's formulations according to the present invention and examined in the present example are shown in the following table herein below.

TABLE-US-00003 Tyrode's solution modified according to Standard Component the present invention Tyrode NaCI 130 mM 137 mM KCl 2.68 mM 2.7 mM D-Glucose 5.5 mM 5.5 mM NaHCO3 11.9 mM 12 mM NaH2PO4 0.46 mM 0.2 mM MgCl2 1.05 mM 1 mM CaCl2 1.8 mM 1.8 mM Vit C 0.1 mM or 1 mM Absent Vit B6 10 mM Absent

[0037] At the time of the experiment, the cells, detached by trypsin treatment and after centrifugation and washing in sterile buffer (PBS), were suspended in the various solutions prepared and then counted with an automatic cell counter.

[0038] During the 24 h incubation, the cells were maintained in the incubator as for the amplification step.

[0039] The cell cultures were then assessed for viability (MTT assay) and proliferation (cell counting).

[0040] The results of the above tests are reported in FIGS. 1 and 2, respectively.

[0041] As can be seen after a 24 hours' incubation in serum-free media (PBS and Tyrode's standard) the cells have in fact completely lost their viability. In the case of culture medium DMEM with serum, the cells have more than 90% of survival that drops to just over 60% in DMEM without serum, however in the presence of high doses of amino acids, vitamins, and 25 mM glucose, which is five times the standard concentration. The modified Tyrode's solutions according to the present invention instead maintain the cells viable up to 30% after 24 hours, a much better result than the standard Tyrode's solution, but also than the culture liquid containing PBS only.

[0042] The two modified Tyrode's solution, object of the present invention and examined, show a significantly better proliferation compared to standard formulation containing PBS only and the standard Tyrode, although obviously lower than DMEM formulations that are markedly much more rich in amino acids and micronutrients.